Home LiteratureArticle Details
PMID: 8339382 Published · ppublish English Comparative Study Journal Article

Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.

Cancer chemotherapy and pharmacology ·Vol. 32 ·No. 5 ·1993-00-00 ·Pages 333-8

Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishitsuka H

Abstract

The present study shows that various cytokines such as tumor necrosis factor (TNF alpha), interleukin-1 alpha (IL-1 alpha), and interferon-gamma (IFN gamma) make tumor cells much more susceptible to the cytostatic 5'-deoxy-5-fluorouridine (5'-dFUrd) than to 5-fluorouracil (5-FUra) and other cytostatics. These three cytokines increased the susceptibility of human cancer cell lines (COLO201, MKN45 and WiDr) but did not affect that of normal fibroblast WI38 cells. The cytokine mixture induced a 50-fold increase in the susceptibility of COLO201 to 5'-dFUrd, whereas a 12-fold increase and a less than 5-fold enhancement in the susceptibility to 5-FUra and other cytostatics, respectively, were observed. The increased susceptibility would be a result of the induction of thymidine phosphorylase (TdR Pase), which is the essential enzyme for the conversion of 5'-dFUrd to 5-FUra. The cytokine mixture increased TdR Pase activity by up to 47 times and greatly induced its mRNA expression in the cancer cell lines. These results suggest that the therapeutic benefit of 5'-dFUrd would be improved by its use in combination with the cytokines.

MeSH Terms
Antineoplastic Agents/pharmacology Blotting, Northern Cell Division/drug effects Colonic Neoplasms/pathology Cytokines/pharmacology Depression, Chemical Drug Synergism Enzyme Induction Floxuridine/pharmacology Fluorouracil/pharmacology Humans Interferon-gamma/pharmacology Interleukin-1/pharmacology RNA, Messenger/biosynthesis Stomach Neoplasms/pathology Thymidine Phosphorylase/biosynthesis Tumor Cells, Cultured/drug effects,enzymology,pathology Tumor Necrosis Factor-alpha/pharmacology
Chemicals
Antineoplastic Agents Cytokines Interleukin-1 RNA, Messenger Tumor Necrosis Factor-alpha Floxuridine Interferon-gamma Thymidine Phosphorylase Fluorouracil doxifluridine
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Eda H
Department of Oncology, Nippon Roche Research Center, Kanagawa, Japan.
Fujimoto K
Watanabe S
Ura M
Hino A
Tanaka Y
Wada K
Ishitsuka H
References (30)
30 references, click to expand
  1. Interactions of interferon-alpha 2a with 5'-deoxy-5-fluorouridine in colorectal cancer cells in vitro.
    Eur J Cancer. 1992;28(2-3):368-72 PMID: 1534247
  2. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
    J Exp Med. 1985 Dec 1;162(6):2163-8 PMID: 2999289
  3. Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.
    Chem Pharm Bull (Tokyo). 1983 Jan;31(1):175-8 PMID: 6221809
  4. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8313-7 PMID: 2430284
  5. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.
    Nature. 1989 Apr 13;338(6216):557-62 PMID: 2467210
  6. Comparative studies on the immunosuppressive effect among 5'-deoxy-5-fluorouridine, ftorafur, and 5-fluorouracil.
    Gan. 1980 Apr;71(2):190-6 PMID: 6451468
  7. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Cancer Treat Rep. 1980 Aug-Sep;64(8-9):829-35 PMID: 7448820
  8. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer.
    Cancer. 1989 Mar 15;63(6 Suppl):1036-44 PMID: 2645042
  9. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).
    Proc Natl Acad Sci U S A. 1981 Apr;78(4):2474-7 PMID: 6264478
  10. An improved colorimetric assay for interleukin 2.
    J Immunol Methods. 1986 Nov 6;93(2):157-65 PMID: 3490518
  11. Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents.
    Int J Cancer. 1987 Feb 15;39(2):266-73 PMID: 3804497
  12. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.
    J Immunol. 1985 Dec;135(6):3969-71 PMID: 2999235
  13. Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites.
    Cancer Res. 1988 Sep 1;48(17):4868-73 PMID: 2457431
  14. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
    J Immunol Methods. 1983 Dec 16;65(1-2):55-63 PMID: 6606682
  15. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.
    J Clin Oncol. 1989 Dec;7(12 ):1769-75 PMID: 2585018
  16. Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissues.
    Cancer Lett. 1983 Jan;17(3):239-47 PMID: 6187435
  17. Cytolytic activity of interferon-gamma and its synergism with 5-fluorouracil.
    Int J Cancer. 1984 Oct 15;34(4):495-500 PMID: 6436183
  18. Interferon enhancement of the invasive capacity of Ewing sarcoma cells in vitro.
    Proc Natl Acad Sci U S A. 1982 Jul;79(13):4064-8 PMID: 6180434
  19. 5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow.
    Cancer Res. 1983 Jun;43(6):2525-8 PMID: 6221792
  20. Interferon effects upon fluorouracil metabolism by HL-60 cells.
    Biochem Biophys Res Commun. 1989 Sep 15;163(2):867-74 PMID: 2783128
  21. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
    Gan. 1980 Feb;71(1):112-23 PMID: 6445847
  22. High-efficiency cloning of full-length cDNA; construction and screening of cDNA expression libraries for mammalian cells.
    Methods Enzymol. 1987;154:3-28 PMID: 2828856
  23. Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells.
    Chem Pharm Bull (Tokyo). 1986 Oct;34(10):4225-32 PMID: 2951016
  24. Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine.
    Eur J Cancer. 1980 Apr;16(4):427-32 PMID: 6447071
  25. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors.
    Biochim Biophys Acta. 1990 Apr 23;1034(1):107-13 PMID: 2328255
  26. Decreased immunosuppression associated with antitumor activity of 5-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine.
    Cancer Res. 1983 Jun;43(6):2529-35 PMID: 6221793
  27. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
  28. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.
    Proc Natl Acad Sci U S A. 1982 Feb;79(3):912-6 PMID: 7038689
  29. Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells.
    Biochem Biophys Res Commun. 1992 Feb 14;182(3):1232-9 PMID: 1540167
  30. Angiogenic factor.
    Nature. 1992 Apr 23;356(6371):668 PMID: 1570012
Article Info
Journal
Cancer chemotherapy and pharmacology
Abbr.
Cancer Chemother Pharmacol
ISSN
0344-5704
Published
1993-00-00
Pages
333-8
Language
English
Region
Germany
NLM ID
7806519
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com